Search

everythinglearnresearchcommunity

for

Search:↓

Hair ages due to various factors and treatments like minoxidil and finasteride can help, but more research and better public awareness are needed.

Combinar microagulhamento com óleos essenciais pode ajudar no crescimento do cabelo em homens.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

A gene called HDAC9 might be a new factor in male-pattern baldness.

Activated platelet-rich plasma helps hair growth by boosting growth factors and cell growth pathways in hair cells.

Angiogenin helps hair grow by stimulating cell growth and blood vessel formation.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Acne can appear or persist in adulthood due to hormonal changes, external factors, or substance use, and requires appropriate treatment.

Forsythiaside-A, a natural substance, can protect against hair loss and is more effective than current treatments, potentially making it a good option for hair loss treatment.

Minoxidil promotes hair regrowth, but more research needed for effectiveness and response factors.

Using steroids can increase the risk of heart problems.

Birth control pills can help reduce mild to moderate acne in women.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

The type of PCOS a woman has doesn't strongly predict her skin or metabolic symptoms; obesity is a more important factor.

Women with and without hair loss have similar amounts of exogen hairs, so these hairs are not a key factor in hair loss conditions.

Wharton's jelly secretomes are best for promoting blood vessel growth.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

Androgenic Alopecia, a common hair loss condition, can be effectively treated with finasteride and other treatments.

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Enriched blood plasma speeds up eardrum healing and improves hearing.

Hair follicle stem cells are promising for blood vessel formation and tissue repair.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Insulin or IGF-I is needed for hair growth in newborn mice, while minoxidil helps adult mouse hair grow, suggesting a way to study human hair loss.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Higher LDL cholesterol may increase the risk of hair loss, while HDL cholesterol does not.

Athletes need effective management of skin disorders for their performance and well-being.